Aquinox Pharmaceuticals (AQXP): Dumped By Big Pharmas – ValueWalk Premium

Aquinox Pharmaceuticals (AQXP): Dumped By Big Pharmas

Johnson & Johnson and Pfizer both pruned their holdings in Aquinox Pharmaceuticals following the recent run-up in its shares.

Aquinox Pharmaceuticals (AQXP) soared recently after the company announced positive results from secondary endpoints from its Phase 2 LEADERSHIP trial with AQX-1125 in patients with bladder pain syndrome/interstitial cystitis (BPS/IC).

Aquinox’s improved quarterly earnings
As outlined by ValueWalk, Aquinox Pharmaceuticals unveiled its second quarter results wherein the clinical stage pharmaceutical company . . .


This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.

Saved Articles

The top investors are reading ValuewalkPremium.

Click here to learn why